Ehrlichia chaffeensis DapE Is Essential for Intracellular Growth and Represents a Promising Therapeutic Target
Open Access
- 25 August 2026
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 14 (9) , 1889
Abstract
Ehrlichia chaffeensis is an obligate intracellular bacterium that proliferates within monocytes or macrophages and causes human monocytic ehrlichiosis (HME), an emerging life-threatening zoonosis. Doxycycline is the choice of treatment for HME, yet it has prominent side effects. Host cells lack the lysine biosynthetic pathway; thus, the enzymes in this pathway are essential for bacterial growth and recognized as potential targets for the development of novel antibiotics. Here, we demonstrated that inhibitors targeting DapE, which is a key enzyme in the lysine biosynthetic pathway, especially disulfiram, effectively inhibit E. chaffeensis infection and intracellular growth. Through complementation experiments and peptide nucleic acid-mediated dapE knockdown, we showed that DapE in E. chaffeensis is functional and essential for bacterial intracellular growth. Using purified recombinant protein, we found that DapE induces IL-8 expression in host cells. Finally, we identified that NtrX, the response regulator of the two-component system NtrY/NtrX, regulates dapE expression using an electrophoretic mobility shift assay and a reporter assay. Our findings deepen the understanding of E. chaffeensis pathogenesis as well as illustrate that DapE in E. chaffeensis is a potential therapeutic target for the development of novel HME treatments.Keywords
Funding Information
- National Natural Science Foundation of China (32170199)
- National Natural Science Foundation of China (32470193)
- Nankai University (63241535)
- Nankai University (63241534)
- Tianjin Municipal Science and Technology Committee (22JCYBJC00560)
- Tianjin Municipal Science and Technology Committee (22JCYBJC00790)
This publication has 38 references indexed in Scilit:
- The coordinated action of the enzymes in the L-lysine biosynthetic pathway and how to inhibit it for antibiotic targetsBiochimica et Biophysica Acta (BBA) - General Subjects, 2023
- Interaction of N-succinyl diaminopimelate desuccinylase with orphenadrine and disulfiramJournal of Molecular Structure, 2020
- Interleukin-8 favors pro-inflammatory activity of human monocytes/macrophagesInternational Immunopharmacology, 2018
- Lysine biosynthesis in microbes: relevance as drug target and prospects for β-lactam antibiotics productionApplied Microbiology and Biotechnology, 2013
- Lysine biosynthesis in bacteria: a metallodesuccinylase as a potential antimicrobial targetJBIC Journal of Biological Inorganic Chemistry, 2012
- Molecular and cellular pathobiology ofEhrlichiainfection: targets for new therapeutics and immunomodulation strategiesExpert Reviews in Molecular Medicine, 2011
- Inhibitors of bacterial N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activityBioorganic & Medicinal Chemistry Letters, 2009
- The dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase from Haemophilus influenzae contains two active-site histidine residuesJBIC Journal of Biological Inorganic Chemistry, 2008
- The Dual Biosynthetic Capability of N-Acetylornithine Aminotransferase in Arginine and Lysine BiosynthesisBiochemistry, 1999
- Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular functionJournal of Immunological Methods, 1994